Strategic Roadmap and Financial Performance
Statutory to Adjusted Total Income & Net Profit Reconciliation
AED MN
Total Income (*)
Adjustments for:
FY19
FY20
FY21
1Q - 21
2Q-21
3Q-21
4Q - 21
1Q-22
112.0
74.2
371.0
42.0
215.4
50.8
62.9
46.9
One-Time Receivable Provision at Sukoon
0.0
16.8
0.0
0.0
0.0
0.0
0.0
Gain on Contingent Consideration re Middlesex
(20.1)
0.0
0.0
0.0
0.0
0.0
0.0
Gain on Disposal
0.0
0.0
(202.9)
0.0
(160.3)
(42.6)
0.0
Share of Prior Period Trading Result
(28.7)
(11.4)
(14.5)
(8.5)
(3.6)
(2.5)
0.0
8 888
0.0
0.0
0.0
Total Adjustments
(48.9)
5.4
(217.4)
(8.5)
(163.8)
(45.1)
0.0
0.0
Adjusted Total Income
63.1
79.6
153.7
33.5
51.6
5.7
62.9
46.9
AED MN
Net Profit
FY19
FY20
FY21
1Q-21
2Q-21
3Q - 21
4Q - 21
1Q-22
60.0
10.1
280.8
31.5
203.8
38.5
7.0
32.0
Adjustments for:
One-Time Receivable Provision at Sukoon
0.0
16.8
0.0
0.0
0.0
0.0
0.0
0.0
Gain on Contingent Consideration re Middlesex
(20.1)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Gain on Disposal
0.0
0.0
(202.9)
0.0
(160.3)
(42.6)
0.0
Share of Prior Period Trading Result
(28.7)
(11.4)
(14.5)
(8.5)
(3.6)
(2.5)
0.0
88 88
Transaction Related Costs
3.4
10.5
20.0
0.0
0.1
0.7
19.2
0.1
Non-Recurring Items
0.0
0.0
20.0
0.0
0.0
0.0
20.0
0.0
Total Adjustments
Adjusted Net Profit
(45.5)
15.9
(177.5)
(8.5)
(163.8)
(44.4)
39.1
0.1
14.6
26.0
103.4
23.1
40.1
(5.9)
46.2
32.1
(*) Finance charges in relation to the Royal Hospital for Women & Children have been reclassified from platform income to finance charges in the current period. The prior
period has been restated accordingly.
40
57View entire presentation